Characteristics of patients with SLE
| Variable | |
| Female gender, n (%) | 212 (93.4) |
| Age, years, mean (SD) | 46.3 (13.8) |
| Educational level, years, mean (SD) | 13.3 (3.1) |
| Socioeconomic level, n (%) | |
| Low | 27 (11.9) |
| Medium | 69 (30.4) |
| High | 131 (57.7) |
| Disease duration, years, mean (SD) | 11.6 (7.3) |
| Clinical SLEDAI-2K, mean (SD) | 1.6 (2.9) |
| SLEDAI-2K, mean (SD) | 2.3 (3.3) |
| PGA, mean (SD) | 11.9 (15.4) |
| SDI, mean (SD) | 1.2 (1.5) |
| LFA-REAL ClinRO 0–1400, mean (SD) | 25.4 (34.7) |
| LFA-REAL ClinRO 0–1100, mean (SD) | 23.3 (30.8) |
| LFA-REAL PRO 0–1200, mean (SD) | 241.1 (187.6) |
| LFA-REAL PRO 0–1000, mean (SD) | 190.3 (151.2) |
| LFA-REAL ClinRO domains | |
| Mucocutaneous global 0–100, mean (SD) | 2.23 (8.56) |
| Rash 0–100, mean (SD) | 1.74 (7.73) |
| Alopecia 0–100, mean (SD) | 1.22 (7.53) |
| Ulcers 0–100, mean (SD) | 0.00 (0.00) |
| Musculoskeletal global 0–100, mean (SD) | 6.41 (14.30) |
| Arthralgia/arthritis 0–100, mean (SD) | 6.82 (14.69) |
| Myalgia/myositis 0–100, mean (SD) | 0.99 (6.33) |
| Cardiorespiratory 0–100, mean (SD) | 0.95 (6.90) |
| Neuropsychiatric 0–100, mean (SD) | 2.03 (9.62) |
| Renal 0–100, mean (SD) | 7.88 (16.46) |
| Haematological 0–100, mean (SD) | 2.01 (8.28) |
| Constitutional 0–100, mean (SD) | 1.20 (6.69) |
| Vasculitis 0–100, mean (SD) | 0.33 (3.48) |
| LFA-REAL PRO domains | |
| Rash 0–100, mean (SD) | 19.62 (24.83) |
| Overall arthritis 0–100, mean (SD) | 27.09 (26.54) |
| Joint pain 0–100, mean (SD) | 31.48 (26.45) |
| Joint swelling 0–100, mean (SD) | 21.50 (24.52) |
| Joint stiffness 0–100, mean (SD) | 24.88 (26.52) |
| Muscle pain or aches 0–100, mean (SD) | 32.97 (26.73) |
| Fatigue 0–100, mean (SD) | 34.08 (26.38) |
| Fever 0–100, mean (SD) | 9.53 (19.02) |
| Hair loss 0–100, mean (SD) | 25.46 (26.87) |
| Chest pain 0–100, mean (SD) | 13.66 (22.76) |
| Shortness of breath 0–100, mean (SD) | 10.45 (21.04) |
| Swelling in legs 0–100, mean (SD) | 14.37 (25.00) |
ClinRO, clinician-reported outcome; LFA-REAL, Lupus Foundation of America Rapid Evaluation of Activity in Lupus; PGA, Physician Global Assessment; PRO, patient-reported outcome; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index; SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index 2000.